the SmallCapReview mailing list.
Myriad Genetics: A
personalized medicine company, that focuses on the
development and marketing of predictive, personalized, and
prognostic medicine tests worldwide.
MYGN has a collaboration with AstraZeneca for the
development of an indication for BRACAnalysis CDx.
Aurinia Pharmaceuticals: A
late-stage biopharmaceutical company providing novel products specifically
engineered to treat a limited, targeted patient population suffering from
serious disease states for which there is a high unmet medical need.
Lipocine Inc.: A specialty pharmaceutical company developing innovative
pharmaceutical products for use in men's and women's health using its
proprietary drug delivery technologies. LPCN's clinical development pipeline includes three development
Hispanica International: Is
engaged in the distribution of proprietary, licensed and third party
Hispanic and Ethnic food and beverages throughout the United States.
added over 1,400 retailers to now surpass 2,000 retail locations and will
expand to over 5,000 retail locations. More.
Where Small Cap Stocks Thrive Since
Five Point Investing Guide For This Aging Bull Market...
the dollar and buy small-cap stocks.
Caps Rally On Hopes Of Tax Deal...
Myers Teams Up With Small Cap...
Stocks Cheapest Since 2000...
Are We In The Small Cap Cycle?
World Of Small Cap Opportunities...
To Play The 'Small Cap Effect'...
The Tide Turning In Small Cap And Microcaps' Favor?
Case For Small Caps Post Harvey...
Caps: The Easy Game For Active Managers...
Makes Small Caps Might And Risky...
Reasons To Buy Aurinia Pharmaceuticals (AUPH) Right Now...
Small Caps For The Rest Of 2017...
Small Caps With Sizeable Dividends...
Cap Movers: NVRB Up 63%, SSNI Up 23%, COHU, UP 13%...
Caps To Watch...
Cap IR By The Numbers... Average
Small Cap IR budget: $224,000, with $78,000 spent on external services.
innovative pharmaceutical products for use in men's and women's health using
its proprietary drug delivery technologies."
on LPCN here...
has the deepest diagnostic pipeline across the disease spectrum."
on MYGN here...
has the potential to become a best in class medication and the first
approved treatment for LN in the U.S. and Europe."
on AUPH here...
Bring Latin America And The World To You."
on HISP here...
Subscribers to our Free
newsletter will receive stock reports and news alerts for small-cap stocks
via email. You can sign-up
"A Primer In
is a leading destination for small-cap picks and news. The Purpose of
is to profile and bring awareness to companies with a market cap of
less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap
stocks to watch via various newswires. We will strive to bring you the
undiscovered, the undervalued, and the oversold.
does not give "buy" recommendations, price targets nor
suggest entry and exit points.
"A Look at Small Cap Stocks that may no longer be Small Caps"